1. Thrift, AP, El-Serag, HB, Kanwal, F. (2017) Global epidemiology and burden of HCV infection and HCV-related disease. Nature Reviews Gastroenterology & Hepatology 14(2): 122–132.
Google Scholar | Crossref | Medline2. Heim, MH, Thimme, R. (2014) Innate and adaptive immune responses in HCV infection. Journal of Hepatology 2014, 61(1 Suppl): S14–S25.
Google Scholar | Crossref | Medline3. Ji, F, Li, J, Liu, L, et al. (2021) High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. Journal of Gastroenterology and Hepatology 36(3): 767–774.
Google Scholar | Crossref | Medline4. Ji, F, Wei, B, Yeo, YH, et al. (2018) Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia. Alimentary pharmacology & therapeutics 47(5): 550–562.
Google Scholar | Crossref | Medline5. Hensel, N, Gu, Z, Sagar, et al. (2021) Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection. Nature Immunology 22(2): 229–239.
Google Scholar | Crossref | Medline6. Hartnell, F, Esposito, I, Swadling, L, et al. (2020) Characterizing hepatitis C virus-specific CD4+ T cells following viral-vectored vaccination, directly acting antivirals, and spontaneous viral cure. Hepatology 72(5): 1541–1555.
Google Scholar | Crossref | Medline7. Aregay, A, Owusu Sekyere, S, Deterding, K, et al. (2019) Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses. Journal of Hepatology 71(5): 889–899.
Google Scholar | Crossref | Medline8. Perpiñán, E, Pérez-Del-Pulgar, S, Londoño, MC, et al. (2020) Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies. Journal of Viral Hepatitis 27(12): 1408–1418.
Google Scholar | Crossref | Medline9. Perpiñán, E, Pérez-Del-Pulgar, S, Londoño, MC, et al. (2020) Cirrhosis hampers early and rapid normalization of natural killer cell phenotype and function in hepatitis C patients undergoing interferon-free therapy. Frontiers in Immunology 11: 129.
Google Scholar | Crossref | Medline10. Osuch, S, Laskus, T, Berak, H, et al. (2020) Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C. Scientific Reports 10(1): 16060.
Google Scholar | Crossref | Medline11. Owusu Sekyere, S, Suneetha, PV, Kraft, AR, et al. (2015) A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. Journal of Hepatology 62(1): 31–40.
Google Scholar | Crossref | Medline12. Caraballo Cortés, K, Osuch, S, Perlejewski, K, et al. (2019) Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus. Journal of Viral Hepatitis 26(8): 942–950.
Google Scholar | Crossref | Medline13. Li, L, Duan, M, Chen, W, et al. (2017) The spleen in liver cirrhosis: revisiting an old enemy with novel targets. Journal of Translational Medicine 15(1): 111.
Google Scholar | Crossref | Medline14. Huang, N, Ji, FP, Zhang, S, et al. (2019) Spleen-associated effects on immunity in hepatitis B virus-related cirrhosis with portal hypertension. Journal of Interferon and Cytokine Research 39: 95–105.
Google Scholar | Crossref | Medline15. Huang, N, Ji, F, Zhang, S, et al. (2018) Effect of splenectomy on serum cytokine profiles in hepatitis B virus-related cirrhosis patients with portal hypertension. Viral Immunology 31: 371–378.
Google Scholar | Crossref | Medline16. Nomura, Y, Kage, M, Ogata, T, et al. (2014) Influence of splenectomy in patients with liver cirrhosis and hypersplenism. Hepatology Research 44(10): E100–E109.
Google Scholar | Crossref | Medline17. Yamamoto, N, Okano, K, Oshima, M, et al. (2015) Laparoscopic splenectomy for patients with liver cirrhosis: improvement of liver function in patients with Child-Pugh class B. Surgery 158(6): 1538–1544.
Google Scholar | Crossref | Medline18. Tamai, H, Mori, Y, Shingaki, N, et al. (2015) Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis. Hepatology International 9(1): 67–75.
Google Scholar | Crossref | Medline19. Ji, F, Zhang, S, Huang, N, et al. (2013) Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis. The Brazilian Journal of Infectious Diseases 17(5): 601–605.
Google Scholar | Crossref | Medline20. Hashimoto, N, Shimoda, S, Kawanaka, H, et al. (2011) Modulation of CD4+ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clinical & Experimental Immunology 165: 243–250.
Google Scholar | Crossref | Medline21. Sumida, K, Shimoda, S, Iwasaka, S, et al. (2013) Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C. Clinical & Experimental Immunology 174: 172–178.
Google Scholar | Crossref | Medline22. Sekiguchi, T, Nagamine, T, Takagi, H, et al. (2006) Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection. World Journal of Gastroenterology 12(13): 2089–2094.
Google Scholar | Crossref | Medline23. Zinselmeyer, BH, Heydari, S, Sacristán, C, et al. (2013) PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. Journal of Experimental Medicine 210(4): 757–774.
Google Scholar | Crossref | Medline24. Yokosuka, T, Takamatsu, M, Kobayashi-Imanishi, W, et al. (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. Journal of Experimental Medicine 209(6): 1201–1217.
Google Scholar | Crossref | Medline | ISI25. Kassel, R, Cruise, MW, Iezzoni, JC, et al. (2009) Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology 50(5): 1625–1637.
Google Scholar | Crossref | Medline26. Dong, J, Yang, XF, Wang, LX, et al. (2017) Modulation of Tim-3 expression by antigen-dependent and -independent factors on T cells from patients with chronic hepatitis B virus infection. Frontiers in Cellular and Infection Microbiology 7: 98.
Google Scholar | Crossref | Medline27. Golden-Mason, L, Palmer, BE, Kassam, N, et al. (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. Journal of Virology 83(18): 9122–9130.
Google Scholar | Crossref | Medline28. Okwor, CIA, Oh, JS, Crawley, AM, et al. (2020) Expression of inhibitory receptors on T and NK cells defines immunological phenotypes of HCV patients with advanced liver fibrosis. iScience 23(9): 101513.
Google Scholar | Crossref | Medline29. Lv, X, Yang, F, Guo, X, et al. (2016) Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis. Tumour Biology 37: 8889–8900.
Google Scholar | Crossref | Medline